Causal ML for Acute HF Diuretic Dosing Enters First-in-Human Trial

A causal ML clinical decision support system for diuretic dosing in acute heart failure was presented at TCT2026 and will undergo a first-in-human prospective trial at Israel's Rambam Medical Center. Retrospective results showed improved renal function with no rise in mortality.

2026-11-03 ~ 2026-11-03 · 2 related posts

• Causal ML decision-support system for acute heart failure enters first-in-human trial — ShalitUri · 2026-11-03
• Hospital AI diuretic dosing model shows better kidney function in retrospective results — ShalitUri · 2026-11-03